{"disease":{"id":"sebaceous-hyperplasia","name":"sebaceous hyperplasia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04253418","title":"Nano-Pulse Stimulation (NPS) in Sebaceous Hyperplasia Optimization Study","phase":"NA","overall_status":"TERMINATED","enrollment_count":125,"lead_sponsor_name":"Pulse Biosciences, Inc.","has_results":false},{"nct_id":"NCT03612570","title":"Nano-Pulse Stimulation (NPS) in Sebaceous Hyperplasia","phase":"NA","overall_status":"COMPLETED","enrollment_count":72,"lead_sponsor_name":"Pulse Biosciences, Inc.","has_results":true},{"nct_id":"NCT04539886","title":"Comparative Study Between CellFX and Electrodessication in Sebaceous Hyperplasia (SH) Lesions","phase":"NA","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Pulse Biosciences, Inc.","has_results":true},{"nct_id":"NCT06840470","title":"Investigating the Effect of Topical Imiquimod on Sebaceous Hyperplasia","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"University of Michigan","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}